Clinical Laboratory Services Market Demand Rises in Infectious Disease Testing

The global clinical laboratory services market size was estimated at USD 233.63 billion in 2024 and is projected to reach USD 286.77 billion by 2030, expanding at a CAGR of 3.82% from 2025 to 2030. Market growth is primarily driven by the rising prevalence of chronic diseases and the increasing demand for early diagnostic testing, which continues to strengthen the role of clinical laboratory services in modern healthcare systems.

Key Market Trends & Insights

• North America led the market with a 37.24% revenue share in 2024, supported by advanced healthcare infrastructure and high diagnostic testing volumes.
• The Asia Pacific region is set to record the fastest CAGR of 5.30% over the forecast period due to expanding healthcare access and increasing investments in diagnostic services.
• By test type, clinical chemistry dominated the segment with a 56.60% share in 2024, owing to its wide application in disease diagnosis.
• Based on service provider, hospital-based laboratories accounted for the largest market share in 2024.
• By application, bioanalytical & lab chemistry services led the market with the largest revenue share in 2024.

Market Size & Forecast

• 2024 Market Size: USD 233.63 Billion
• 2030 Projected Market Size: USD 286.77 Billion
• CAGR (2025-2030): 3.82%
• North America: Largest market in 2024
• Asia Pacific: Fastest growing market

Rapid advancements in data and sample management technologies are contributing significantly to market expansion. As sample volumes grow, the need for efficient tools to handle large datasets has become essential. Clinical laboratories play a central role in detecting and quantifying biological substances, providing critical insights into metabolic disorders, infectious and non-infectious diseases, and inflammatory conditions. Accurate and timely diagnosis remains a cornerstone in achieving better patient outcomes.

Automation has transformed clinical workflows by streamlining data management and improving operational efficiency. Increasing adoption of automation systems, along with integrated workflow management tools and centralized patient record databases, is expected to further support market growth. Many companies now process 100 to 150 billion samples annually, emphasizing the importance of robust informatics and automated systems for seamless operations.

The rising global burden of diseases and growing preference for early diagnosis continue to propel the demand for clinical laboratory services. Innovations such as companion diagnostics, biochips, and microarrays have enhanced disease detection accuracy while reducing overall healthcare costs by enabling personalized treatment selection. The increasing prevalence of cardiovascular diseases and diabetes also serves as a major market driver. According to the WHO, cardiovascular diseases could account for 23.6 million deaths by 2030, highlighting the urgent need for advanced diagnostic services. Similarly, the rising number of diabetes cases contributes to expanding test volumes and laboratory service usage.

Order a free sample PDF of the Clinical Laboratory Services Market Intelligence Study, published by Grand View Research.

Key Company Insights

Leading companies in the clinical laboratory services market include Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, QIAGEN NV, Eurofins Scientific SE, Siemens Medical Solutions USA, Inc., and NeoGenomics Laboratories. These players focus on strategic initiatives such as partnerships, collaborations, and geographic expansion to strengthen their market presence.

Emerging participants such as OPKO Health, Inc., ARUP Laboratories, and Sonic Healthcare are increasingly adopting customer acquisition strategies, particularly through collaborations with hospitals and clinics, to accelerate growth and expand their service portfolios.

Key Clinical Laboratory Services Companies

• Laboratory Corporation of America Holdings (LabCorp)
• QIAGEN
• Eurofins Scientific
• Quest Diagnostics Incorporated
• OPKO Health, Inc.
• Siemens Healthineers AG
• NeoGenomics Laboratories
• Fresenius Medical Care
• ARUP Laboratories
• Sonic Healthcare Limited
• Charles River Laboratories
• SYNLAB International
• Mayo Clinic Laboratories
• Unilabs

Conclusion

The clinical laboratory services market continues to evolve rapidly, supported by technological advancements, automation, and the increasing necessity for early and accurate diagnostics. The growing prevalence of chronic diseases and continuous innovation in diagnostic tools are expected to drive sustained demand. With strong contributions from both established and emerging industry players, the market is well-positioned for steady growth through 2030.

Explore Horizon Databook – The world’s most expansive market intelligence platform developed by Grand View Research.